NeXtGen Biologics, Inc.

NeXtGen Biologics, Inc. is a medical device company specializing in regenerative medicine and scar-free wound healing solutions. The company's proprietary technology leverages extracellular matrix (ECM) derived from the axolotl, a salamander renowned for its remarkable regenerative abilities without scarring. NeXtGen's flagship product, NeoMatriX® Wound Matrix, is a collagen-based medical device engineered to support partial and full-thickness wound management in clinical settings. NeoMatriX is available in sheet formats with room-temperature storage capability, offering cost-effective wound care with demonstrated clinical efficacy in applications including post-surgical wounds, diabetic foot ulcers, and Mohs surgery closures. The company is positioned to expand its product pipeline within the North American market, targeting healthcare professionals in wound care and neuromusculoskeletal regeneration specialties.